WILMINGTON, DE — AstraZeneca (NYSE: AZN) said full results from the Phase III KALOS and LOGOS trials, published in The Lancet ...

AstraZeneca secured a Federal Court injunction in Australia blocking Pharmacor from selling generic dapagliflozin while a ...

WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca will showcase new clinical and real-world data across its leading inhaled, biologic and early science respiratory portfolio at the American Thoracic ...

AstraZeneca PLC (NASDAQ:AZN) is one of the best immunotherapy stocks to buy according to hedge funds. AstraZeneca PLC (NASDAQ:AZN) received an update from Deutsche Bank on February 16, with the firm ...

Full results from the positive Phase III KALOS and LOGOS trials published in The Lancet Respiratory Medicine showed AstraZeneca’s BREZTRI Aerosphere (budesonide/glycopyrronium/formoterol fumarate or ...

WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (AZN) will present the latest clinical and real-world data across its leading inhaled, biologic and early science respiratory portfolio at the American ...

Full results from the positive Phase III KALOS and LOGOS trials have been published in The Lancet Respiratory Medicine.

(Alliance News) - Astrazeneca on Friday hailed positive results from a phase-three trial of its asthma treatment breztri aerosphere. Shares in the Cambridge, England-based pharmaceutical company rose ...

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, released its fourth annual TGaS Digital Marketing Competency ...

Breztri can cost $400 or more without insurance, but Medicare may cover inhaler drugs for COPD, including Breztri. That said, the specific coverage and costs vary based on your exact plan. Breztri ...